Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria

International Archives of Allergy and Immunology

Volumn 154, Issue 2, 2011, Pages 177-180

  Metz, Martin ^a   Altrichter, Sabine ^a   Ardelean, Elena ^a   Keßler, Birgit ^a   Krause, Karoline ^a   Magerl, Markus ^a   Siebenhaar, Frank ^a   Weller, Karsten ^a   Zuberbier, Torsten ^a   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Immunoglobulin E; Mast cell; Omalizumab; Urticaria

Indexed keywords

ANTIBIOTIC AGENT; CETIRIZINE; CLEMASTINE; DESLORATADINE; EBASTINE; FEXOFENADINE; HYDROXYZINE; IMMUNOGLOBULIN E; LEVOCETIRIZINE; LORATADINE; MONTELUKAST; OMALIZUMAB; RANITIDINE; RUPATADINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLD URTICARIA; DERMOGRAPHISM; FEMALE; HEAT URTICARIA; HUMAN; MALE; PRESSURE URTICARIA; PRIORITY JOURNAL; PROVOCATION TEST; SOLAR URTICARIA; URTICARIA;

ADULT; ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 77956078962     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320233     Document Type: Article

References (17)

1. Magerl M, Borzova E, Gimenez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Metz M, Mlynek A, Maurer M: The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/ EDF/UNEV consensus panel recommendations. Allergy 2009; 64: 1715-1721
2. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez- Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M: EAACI/GA(2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426
3. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez- Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B: EAACI/GA(2) LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-1443
4. Grabbe J: Pathomechanisms in physical urticaria. J Investig Dermatol Symp Proc 2001; 6: 135-136
5. Hughes R, Cusack C, Murphy GM, Kirby B: Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol 2009; 34:e660-e662
6. Chang TW, Shiung YY: Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 2006; 117: 1203-1212
7. Boyce JA: Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006; 117: 1415-1418
8. Güzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M: Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 2008; 63: 1563-1565
9. Bindslev-Jensen C, Skov PS: Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010; 65: 138-139
10. Bullerkotte U, Wieczorek D, Kapp A, Wedi B: Effective treatment of refractory severe heat urticaria with omalizumab. Allergy 2009, Epub ahead of print
11. Metz M, Bergmann P, Zuberbier T, Maurer M: Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 2008; 63: 247-249
12. Magerl M, Schmolke J, Metz M, Zuberbier T, Siebenhaar F, Maurer M: Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin Exp Dermatol 2009; 34:e137-e140
13. Metz M, Scholz E, Ferran M, Izquierdo I, Gimenez- Arnau A, Maurer M: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010; 104: 86-92
14. Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M: High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard- dose treatment in patients with acquired cold urticaria: a randomized, placebo- controlled, crossover study. J Allergy Clin Immunol 2009; 123: 672-679
15. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK: Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008; 122: 569-573
16. Romano C, Sellitto A, De Fanis U, Esposito G, Arbo P, Giunta R, Lucivero G: Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria. Ann Allergy Asthma Immunol 2010; 104: 95-97
17. Spector SL, Tan RA: Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007; 99: 190-193